George Jabbour is a Cardiology physician affiliated with University of Pittsburgh. OpenAlex indexes 7 publications with 268 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1414 9th Ave
Station Medical Center
Altoona, PA 166022415
Telephone
814-946-1655Registry record last updated 6 Apr 2021.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202573 payments$57,168openpaymentsdata.cms.gov ↗
- Recor Medical IncProgram year20253 payments
- Medtronic, Inc.Program year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.5%Beta blocker18.1%Metoprolol Succinate54%Carvedilol27%Metoprolol Tartrate12%Atenolol3%Labetalol Hcl1%Sotalol1%Bisoprolol Fumarate1%Propranolol Hcl0%Propranolol Hcl Er0%Bisoprolol-Hydrochlorothiazide0%Carvedilol Er0%Part D<11 patientsStatin15.2%Atorvastatin Calcium66%Rosuvastatin Calcium29%Simvastatin3%Pravastatin Sodium2%Part D≥1113 patients+ 21 more classes in this area
Blood & clotting
14.4%Factor Xa inhibitor6.8%Eliquis82%Xarelto18%Part D≥510 patientsP2Y12 inhibitor6.8%Clopidogrel98%Brilinta1%Prasugrel Hcl1%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
5.8%Potassium supplement2.8%Potassium Chloride93%Klor-Con M205%Klor-Con2%Part D<11 patientsSGLT2 inhibitor2.7%Jardiance98%Farxiga2%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure
JACC: Cardiovascular Interventions
2023 - Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
Journal of the American College of Cardiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”